CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

The Advent of Patient-centricity: What Does it Actually Mean?

There is a lot of buzz in the pharmaceutical and healthcare

industry right now around the concept of ‘patientcentricity’.

The term can mean many different things to a

lot of different factions within the healthcare space. With

high-profile headlines about drug pricing in the market,

the industry is coming around to the enlightening thought

that it ought to be more overtly focused on the patient.

Justin Schroeder, Executive Director, Marketing, Business

Development & Design at PCI Pharma Services explains this

is now borne out in many facets of the business.

https://international-pharma.com/wp-content/uploads/2017/04/The-Advent.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026